Signal Transduction and Human Disease

Передняя обложка
Toren Finkel, J. Silvio Gutkind
John Wiley & Sons, 18 июл. 2003 г. - Всего страниц: 488
This book uniquely relates the broad impact of signal transduction research on the understanding and treatment of human disease. There have been significant advances in the area of signaling in disease processes, yet no resource presently connects these advances with understanding of disease processes and applications for novel therapeutics. Given the emphasis on translational research and biological relevance in biotechnology, and, conversely, the importance of molecular approaches for clinical research, it is evident that a single resource bridging signaling research and human disease will be invaluable.

Результаты поиска по книге

Избранные страницы

Содержание

1 Atherosclerosis Signal Transduction by Oxygen and Nitrogen Radicals
1
2 NFkBA Key Signaling Pathway in Asthma
23
3 Molecular Mechanisms of Cancer
71
4 Apoptotic Pathways in Cancer Progression and Treatment
143
5 Molecular and Cellular Aspects of Insulin Resistance Implications for Diabetes
171
6 Dysfunction of G ProteinRegulated Pathways and Endocrine Diseases
201
7 Bacterial Regulation of the Cytoskeleton
233
8 Bacterial Toxins and Diarrhea
259
9 Molecular Basis of Severe Combined Immunodeficiency Lessons from Cytokine Signaling Pathways
279
10 Mast CellRelated Diseases Genetics Signaling Pathways and Novel Therapies
307
11 Rheumatology and Signal Transduction
357
12 Molecular Mechanisms of Neurodegenerative Disorders
377
13 Neurotrophic Signaling in Mood Disorders
411
14 Inhibiting Signaling Pathways Through Rational Drug Design
447
Index
459
Авторские права

Другие издания - Просмотреть все

Часто встречающиеся слова и выражения

Об авторе (2003)

Dr. Toren Finkel is Chief of the Cardiovascular Branch, National Heart Lung and Blood Institute, National Institutes of Health (NIH, DHHS). He received his undergraduate training in physics and then completed a combined M.D./Ph.D. program at Harvard Medical School. Following graduation he pursued an internal medical residency at the Massachusetts General Hospital in Boston and a Cardiology Fellowship at Johns Hopkins School of Medicine in Baltimore. His laboratory has been interested in the role of oxidants as signaling molecules and the participation of free radicals in human disease.

Dr. J. Silvio Gutkind is Chief of the Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH, DHHS). He received his Ph.D. in pharmacy and biochemistry from the University of Buenos Aires, Argentina. His laboratory has addressed the molecular basis of cancer by studying normal and aberrant functions of molecules involved in the transduction of proliferative signals. He also leads a multi-institutional effort aimed to elucidate the molecular changes that contribute to the evolution of squamous cell carcinomas.

Библиографические данные